XPD could suppress growth of HepG2.2.15 and down-regulate the expression of hepatitis B virus x protein through P53

Hao Ding1, Jiang-jing Xu, Yuan Huang

  • 1Department of Gastroenterology, Second Affiliated Hospital, Nanchang University, Nanchang, PR China.

Abstract

Insights

Xeroderma pigmentosum D (XPD) suppresses hepatoma cell growth by regulating P53 pathway genes, including P21 and Bax. XPD

Area of Science:

  • Hepatocellular carcinoma research
  • Molecular oncology
  • DNA repair mechanisms

Background:

  • Hepatoma cell growth is complex and influenced by various proteins.
  • The role of Xeroderma pigmentosum D (XPD) in hepatocarcinogenesis is not fully understood.
  • The P53 pathway is a critical regulator of cell cycle and apoptosis in cancer.

Purpose of the Study:

  • To investigate the effect of XPD on hepatoma cell growth.
  • To analyze the impact of XPD on P21, Bax, Bcl-2, and Hepatitis B virus X protein (HBx) expression.
  • To determine if XPD influences these genes via the P53 pathway.

Main Methods:

  • Transfection of human hepatoma cells (HepG2.2.15) with XPD expression vector.
  • Inhibition of the P53 pathway using Pifithrin-α.
  • Analysis of gene expression (RT-PCR, Western blotting) and cell behavior (flow cytometry, MTT assay).

Main Results:

  • XPD overexpression increased P53, phospho-P53, P21, and Bax levels, while decreasing Bcl-2 and HBx.
  • XPD inhibited hepatoma cell viability and promoted apoptosis.
  • Inhibition of P53 abolished the effects of XPD on cell growth and apoptosis.

Conclusions:

  • XPD suppresses hepatoma cell growth by modulating P53 pathway targets P21, Bax, Bcl-2, and HBx.
  • XPD's influence on hepatocarcinogenesis may involve intricate interactions with P53 and HBx.
  • Targeting XPD could be a potential therapeutic strategy for hepatocellular carcinoma.